Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Per Videhult1

  • 1Kirurgkliniken - Västerås, Sweden Kirurgkliniken - Västerås, Sweden.

Lakartidningen
|January 11, 2018
PubMed
Summary
This summary is machine-generated.

Gastric bypass surgery (GBP) leads to significant weight loss and improves obesity-related conditions like type II diabetes, hypertension, and sleep apnea. The surgery

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Rising incidence of acute pancreatitis in Sweden: National estimates and trends between 1990 and 2013.

United European gastroenterology journal·2020
Same author

[Do we overtreat patients? Heavily increased risk for ERCP pancreatitis after treatment for asymptomatic common bile duct stones].

Lakartidningen·2019
Same author

Pancreatic Cancer Following Acute Pancreatitis: A Population-based Matched Cohort Study.

The American journal of gastroenterology·2018
Same author

[Nordic guidelines for follow-up after obesity surgery].

Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke·2018
Same author

Lakartidningen·2018
Same author

[Gastric bypass versus sleeve, pros and cons].

Lakartidningen·2017

Area of Science:

  • Bariatric surgery
  • Endocrinology
  • Metabolic disease management

Background:

  • The first gastric bypass (GBP) surgery for obesity was performed in 1967.
  • Initial observations noted substantial weight loss in patients undergoing surgery for gastric ulcers.

Observation:

  • Gastric bypass surgery results in an average weight loss of 30%.
  • Significant improvements are observed in comorbidities associated with obesity.

Findings:

  • Two-thirds of type II diabetes patients can discontinue medication post-GBP.
  • Half of patients achieve remission from hypertension and hyperlipidemia.
  • 75% of patients are cured of reflux and obstructive sleep apnea.
  • Weight loss and diabetes remission are primarily driven by endocrine mechanisms, not just restriction or malabsorption.

Related Experiment Videos

  • Enhanced passage of food to the distal small bowel stimulates satiety hormone release.
  • Elevated satiety hormones promote weight loss, increase insulin secretion, and counteract metabolic rate decrease during fasting.

    • Implications:

    • Gastric bypass surgery offers significant health benefits and improves survival rates, particularly for diabetic patients.
    • The endocrine mechanisms activated by GBP provide a novel approach to managing obesity and related metabolic disorders.
    • Understanding these hormonal pathways can inform future therapeutic strategies for weight management and diabetes remission.